Advertisement

Journal of Thrombosis and Thrombolysis

, Volume 7, Issue 2, pp 149–152 | Cite as

Management of Hemorrhagic Events in Patients Receiving Anticoagulant Therapy

  • Donald G. Love
Article

Keywords

Public Health Anticoagulant Therapy Hemorrhagic Event 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Levine MN. Hemorrhagic complications of anticoagulant treatment. Chest 1995; 108:276S–290S.PubMedGoogle Scholar
  2. 2.
    Landefeld CS. Rosenblatt MW, Goldman L. Bleeding in outpatients treated with warfarin: Relation to the prothrombin time and important remediable lesions. Am J Med 1989;87:144–152.PubMedGoogle Scholar
  3. 3.
    Levine M, Goldhaber SZ, Gore JM. Hemorrhagic complications of thrombolytic therapy in the treatment of myocardial infarction and venous thromboembolism. Chest 1995;108:291S–301S.PubMedGoogle Scholar
  4. 4.
    Weitz J, Califf RKM, Ginsberg JS, Hirsh J, Theroux P, New antithrombotics. Chest 1995;108:471S–485S.PubMedGoogle Scholar
  5. 5.
    Landefeld S, Beyeth R. Anticoagulant-Related Bleeding: Clinical epidemiology, prediction, and prevention. AmJMed 1993;95:315–328.Google Scholar
  6. 6.
    Julius C, Westphal RG. The safety of blood components and derivative. Hematol Oncol North Am 1992;6:1057–1077.Google Scholar
  7. 7.
    Hirsh J. Oral anticoagulants, mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 1995;108:231S–246S.PubMedGoogle Scholar
  8. 8.
    Brophy MT, Fiore LD, Deykin D. Low-dose Vitamin K therapy in excessively anticoagulated patients: A dose-finding study. J Thromb Thrombos 1997;4:289–292.Google Scholar
  9. 9.
    Martin JC. Anaphylactoid reactions and vitamin K. Med J Aust 1991;155:851.Google Scholar
  10. 10.
    Lefrere JJ, Girot R. Acute cardiovascular collapse during intravenous vitamin K injection. Thromb Haemost 1987;58:790.PubMedGoogle Scholar
  11. 11.
    Rich EC, Drage CW. Severe complications of intravenous phytonadione therapy—Two cases, with one fatality. Postgard Med J 1982;72:303–306.Google Scholar
  12. 12.
    Fernandez F, Nguyen P. van Ryn J, et al. Hemorrhagic doses of heparin and other glycosaminoglycans induce a platelet defect. Thromb Res 1986;43:491–495.PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1999

Authors and Affiliations

  • Donald G. Love
    • 1
  1. 1.Harvard UniversityCambridge

Personalised recommendations